Evolutionary Action Score Identifies a Subset of TP53 Mutated Myelodysplastic Syndrome with Favorable Prognosis, Rashmi Kanagal-Shamanna, Guillermo Bravo, Panagiotis Katsonis, Koji Sasaki, Caleb Class, Christopher Benton, Elias Jabbour, Kelly Chien, Rajyalakshmi Luthra, Carlos Bueso-Ramos, Tapan Kadia, Michael Andreeff, Nicholas Short, Naval Daver, Mark Routbort, Joseph Khoury, Keyur Patel, Irene Ganan-Gomez, Yue Wei, Gautam Borthakur, Farhad Ravandi, Kim-Anh Do, Kelly Soltysiak, Olivier Lichtarge, L. Medeiros, Hagop Kantarjian, Guillermo Garcia-Manero
Scholarship and Professional Work – COPHS

Hypomethylating Agents Do Not Alter Novel Splicing Events in Myeloid Neoplasms, Hussein Abbas, Feng Wang, Yue Wei, Hui Yang, Guillermo Bravo, Rashmi Kanagal-Shamanna, Caleb Class, Faezeh Darbaniyan, Jianhua Zhang, Andy Futreal, Guillermo Garcia-Manero
Scholarship and Professional Work – COPHS

KDM6B Overexpression and TET2 Deficiency Cooperatively Drive Development of Myelodysplastic Syndrome and Chronic Myelomonocytic Leukemia-like Phenotype in Mice, Yue Wei, Hong Zheng, Naran Bao, Rashmi Kanagal-Shamanna, Caleb Class, Hui Yang, Guillermo Bravo, Irene Ganan-Gomez, Kelly Soltysiak, Kim-Ann Do, Simona Colla, Carlos Bueso-Ramos, Guillermo Garcia-Manero
Scholarship and Professional Work – COPHS